Process versus outcome: the sugar window

MeSH terms

• Biomarkers / blood
• Blood Glucose / drug effects*
• Blood Glucose / metabolism
• Cardiac Surgical Procedures* / adverse effects
• Cardiac Surgical Procedures* / economics
• Cardiac Surgical Procedures* / standards
• Cost-Benefit Analysis
• Drug Costs
• Guideline Adherence
• Humans
• Hyperglycemia / blood
• Hyperglycemia / diagnosis
• Hyperglycemia / drug therapy*
• Hyperglycemia / economics
• Hyperglycemia / etiology
• Hypoglycemic Agents / adverse effects
• Hypoglycemic Agents / economics
• Hypoglycemic Agents / therapeutic use*
• Insulin / adverse effects
• Insulin / economics
• Insulin / therapeutic use*
• Outcome and Process Assessment, Health Care* / economics
• Outcome and Process Assessment, Health Care* / standards
• Practice Guidelines as Topic
• Quality Indicators, Health Care
• Risk Factors
• Surgical Wound Infection / etiology
• Surgical Wound Infection / prevention & control
• Time Factors
• Treatment Outcome